Peak steps to measure ‘‘capacity for activity’’: Actigraphy in the ADAPT registry with oral treprostinil
Pulmonary arterial hypertension (PAH) patients have low activity time. Actigraphy provides an objective quantification of movement outside of clinic visits (home, work, social activities). Summary actigraphy measures (total daily steps or activity time) have not been shown to increase after adding t...
Saved in:
| Main Authors: | Daniel Lachant, DO, James Gagermeier, MD, Scott Seaman, PhD, Andrew Wang, MPH, Meredith Broderick, PharmD, JD, R. James White, MD, PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | JHLT Open |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S295013342500014X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overcoming Intrapulmonary Shunting: A Case Report of Hepatopulmonary Syndrome Post‐Liver Transplantation Treated With Inhaled Treprostinil
by: John Fanous, et al.
Published: (2025-05-01) -
Long‐Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension)
by: Pavel Jansa, et al.
Published: (2025-04-01) -
Congruency between clinician‐assessed risk and calculated risk of 1‐year mortality in patients with pulmonary arterial hypertension: A retrospective chart review
by: Amresh Raina, et al.
Published: (2024-10-01) -
Validation of MotionWatch8 Actigraphy Against Polysomnography in Menopausal Women Under Warm Conditions
by: Xinzhu Li, et al.
Published: (2025-05-01) -
The two ends of the spectrum: comparing chronic schizophrenia and premorbid latent schizotypy by actigraphy
by: Szandra László, et al.
Published: (2025-05-01)